Raymond James Financial’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
6CM
Raymond James Financial's PHAT Position: Q3 2026 in Review
Raymond James Financial reduced its Phathom Pharmaceuticals (PHAT) stake by 7.1% in Q3 2026, selling an estimated $32.3K and leaving 44,597 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #4814.
Raymond James Financial first reported a position in PHAT in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.7M in Q4 2024. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.
- Raymond James Financial held 44,597 shares of Phathom Pharmaceuticals worth $326K as of Q3 2026.
- Raymond James Financial sold 3,427 Phathom Pharmaceuticals shares in Q3 2026, an estimated $32.3K.
- Phathom Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #4814 holding.
- Raymond James Financial first reported a position in Phathom Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- Raymond James Financial's Phathom Pharmaceuticals position peaked at $3.7M in Q4 2024.
- 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.